Environmental Impact Acquisition today announced that it has achieved a quorum for the shareholders meeting set for Feb. 1 to approve the proposed merger with GreenLight Biosciences, a biotechnology company.
The business combination, if ultimately approved by ENVI shareholders during the formal vote, is expected to close Feb. 2. Greenlight stock is expected to begin trading the next day on the Nasdaq under the ticker symbol GRNA.
ENVI has yet to announce redemptions, if any.
As announced in August, the transaction would provide estimated proceeds of $282 million, assuming no redemptions, although the SPAC has since plumped up its PIPE financing by an additional $10 million. Read more.
